Status:

COMPLETED

Different Doses of Colchicine on hsCRP

Lead Sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions:

Coronary Artery Disease

Percutaneous Coronary Intervention

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Colchicine reduced atherothrombotic cardiovascular events in the COLCOT and LoDoCo2 studies. US Food and Drug Administration approved colchicine as the first anti-inflammatory drug for cardiovascular ...

Eligibility Criteria

Inclusion

  • Volunteer to participate, understand and sign an informed consent form;
  • Age ≥ 18 years old, regardless of gender;
  • Patient diagnosed with coronary heart disease requiring percutaneous coronary intervention;
  • Complete all planned percutaneous coronary intervention during hospitalization;
  • Patient must be treated according to national guidelines for standard treatment of coronary heart disease.

Exclusion

  • Known allergies to colchicine;
  • Colchicine was taken within 10 days before randomization;
  • Abnormal liver function test (alanine aminotransferase \>3 times the upper limit of normal value);
  • Abnormal renal function test (eGFR\<30mL/min);
  • Thrombocytopenia (platelet count \<100 g/L);
  • Uncontrolled infectious diseases;
  • Known immune diseases or immune-related diseases such as systemic lupus erythematosus, asthma, inflammatory bowel disease, gout, and malignant tumor, etc;
  • Pre-existing or plan for the administration of nonsteroidal anti-inflammatory drugs, hormones, immunomodulatory drugs, or chemotherapeutic drugs;
  • Pregnant women, lactating women or women of childbearing age who do not use effective contraceptives;
  • Any other circumstances in which the investigator judges that the patient is not suitable to participate in the clinical trial.

Key Trial Info

Start Date :

October 10 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2024

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06078904

Start Date

October 10 2023

End Date

April 15 2024

Last Update

April 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430022